Terapia Con Everolimus Nel Trapianto de Novo di Fegato: Uno Studio Multicentrico Randomizzato.

Next Previous
Trial Profile

Terapia Con Everolimus Nel Trapianto de Novo di Fegato: Uno Studio Multicentrico Randomizzato.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Everolimus (Primary) ; Basiliximab; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms EPOCAL

    • Most Recent Events

    • 16 Sep 2015 Status changed from recruiting to completed, according to an abstract presented at the 17th Congress of the European Society for Organ Transplantation.
    • 16 Sep 2015 Primary endpoint has been met. (Biopsy-proven rejection episodes (BPAR)), according to an abstract at the 17th Congress of the European Society for Organ Transplantation.
    • 16 Sep 2015 Results presented at the 17th Congress of the European Society for Organ Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top